Bart J. Hellebrekers
The Hague, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Intravaginal Delivery of Oxybutynin: An Alternative Administration Route to Improve its Pharmacokinetic and Pharmacodynamic Effects.
Journal: European urology open science
Published: July 09, 2026
A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy.
Journal: International journal of cancer
Published: March 25, 2020
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 26, 2015
Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy.
Journal: International journal of cancer
Published: September 18, 2013
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.
Journal: Cancer immunology, immunotherapy : CII
Published: July 16, 2013
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.
Journal: Cancer immunology, immunotherapy : CII
Published: February 13, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026